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A solid phase extraction technique was developed to aid
in removing interfering substances from the cockroach brain
extract. Quantitative analysis of octopamine was
subsequently achieved by HPLC with amperometric
electrochemical detection. The procedure affords 80 to 100
percent recovery of octopamine. The presence of octopamine
in brain extract was confirmed by GC-MS.
The daily pattern of brain octopamine levels in
cockroach Leucophaea maderae was investigated using the
HPLC-EC assay procedure. It was concluded that the
concentration of brain octopamine in the cockroach L.





As early as 1940(1) and 1948 (2), Erspamer(11 2)
observed that extracts of posterior salivary glands of
Octopus vu1garis, when irradiated with ultraviolet light in
the presence of air, possessed intense adrenaline-like
actions on blood pressure and isolated organs. Erspamer
isolated the active constituent of the posterior salivary
glands of Octopus vulgaris in 1952, determined its identity
using two-dimensional paper chromatography to be 1-p-
hydroxyphenylethanolamine, and named it octopamine(3).
Erspamer(3) was not able to detect octopamine in other
tissues of the octopus or in extracts from the tissues of
vertebrates or other invertebrates.
B. Biologiaal significance of octopamine 
The research activities involving octopamine are largely
aimed at elucidating biological significance of this
compound, in particular its possible involvement in adverse
medical conditions of humans and other mammals. The urinary
excretion of large amounts of the octopamine metabolite
2
homovanillic acid (HMVA) in phenylketonurics suggests its
role in the disease. Octopamine causes a transient elevation
of blood pressure in mammals(1,2). It has been proposed
that the increased level of octopamine acting as a false
neurotransmitter causes hepatic encephalopathy(4,5).
Administration of tricyclic antidepressants, in particular
iprindol, which acts selectively on the enzyme B monoamine
oxidase (MAO), causes an increase in the brain octopamine
levels in patients being treated for depression(6).
Octopamine at these increased levels displaces both the
noradrenaline (NA), and adrenaline (AD) allowing octopamine
to act as a false neurotransmitter. It has been shown that
the physiological action of octopamine is only 1/50 as
effective as that of NA, and because of this octopamine is
thought simply to modify the actions of NA( 7). The insect
nervous system has the potential to provide a screening tool
for new antidepressant drugs because of the high affinity
sodium independent uptake mechanism for octopamine and the
potential for subsequent inactivation of any neurally
released octopamine.
It has been postulated that the effectiveness of MAO
inhibitors used in the lowering of blood pressure is due to
the false transmitter action of octopamine in displacing
stored NA thereby lowering the NA(8). NA is implicated in
high blood pressure in mammals, including humans. Studies
with octopamine have found that the octopamine also acts as
a co-transmitter with NA(9). The function of octopamine in
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the vertebrates has yet to be fully ascertained. Octopamine
in the vertebrate system coexists with NA in much lower
concentration. It is released along with NA, and it may
modify the action of this neurotransmitter. It has been
detected in the heart, submandibular glands, adrenal glands
(9), spleen, and vas deferens("). A high concentration of
octopamine is generally found in the sympathetically
innervated peripheral tissues. Octopamine disappears if the
tissues are surgically deprived of sympathetic
innervation(") suggesting the source of octopamine from the
nervous system. The question surrounding the storage of
octopamine has yet to be answered. Octopamine has been
found in denervation resistant salivary gland, suggesting
that octopamine might be stored in location other than
sympathetic nerve endings(11).
In the invertebrates, the octopamine is present in
significantly higher concentration. The distribution of
octopamine in the cockroach, Periplaneta americana, nervous
system was studied by Evans et al. (12)• The study found the
highest concentration of octopamine in the cerebral ganglion
(14.68 pmol/piece of tissue), followed by suboesophagial
ganglion (5.60 pmol/piece of tissue), prothoracic ganglion
(5.28 pmol/pice of tissue), terminal abdominal ganglion
(5.26 pmol/piece of tissue), mesothoracic ganglion (4.33
pmol/piece of tissue). A small amount of octopamine is
present in the cockroach retina (0.62 pmol/piece of tissue).
The amount of octopamine present in the cockroach brain is
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similar to the amounts of dopamine and p-hydroxytyramine
(13). Octopamine is widely distributed in the cockroach
nervous system, and its role has to date not been
identified. Nathason and Greengard(14) have demonstrated
the role of octopamine as a neurotransmitter in the
cockroach. Their study found the existence of a naturally
occurring octopamine sensitive adenylate cyclase. Robertson
et al. (15) found that octopamine activates phosphorylase in
the cockroach nerve cord, suggesting that this
glycogenolytic effect might be mediated through an increased
cyclic AMP. If this is true, then octopamine acts as a
neurotransmitter. The existence of octopamine sensitive
adenylate cyclase provides a possible mechanism by which
octopamine could be involved in the regulation of
carbohydrate metabolism as well as in the physiology of
synaptic transmission. The possibility that octopamine
levels may vary temporaly can not at this time be ruled out.
It is suspected that octopamine has multiplicity of roles,
and its effect may be analogous to NA in the vertebrate
nervous system. It has been shown by Evans and O'Shea
(16), that in the locust, one of the dorsal unpaired medial
neurons of the metathoracic ganglion is a octopaminergic
neuromodulatory cell. Its function as a neurotransmitter,
and a neuromodulator has been established (131 17, 18) 
Saavedra and Brownstein(19) have demonstrated the presence
of octopamine in the marine mollusc, Aplysia californica,
ganglia and in single neurons. The researchers observed
....-............
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that only the octopamine was present in the neural cells.
They noted the absence of catecholamines, which led them to
conclude that the octopamine acts as a neurotransmitter in
Aplysia californica. The study concerning the effects of
octopamine on neurones of A. californica by Hicks et al. (20)
showed that the octopamine containing cell governs the
nature of the post-synaptic cell's response. Octopamine
elicits an increase of cyclic AMP in the target cell. The
possible role of an increased cyclic AMP in the target cell
of the locust has not been elucidated. In the locust, the
neurons extending along both sides of the insect have been
determined to be octopaminergic(21, 22). Octopamine at low
concentration inhibits the contraction rhythm of the muscle.
The inhibition of the rhythmic muscle contraction is
believed to be mediated by a group of myogenic fibers and is
similar to alpha-adrenergic properties. These properties
are also noted in the octopamine specific adenylate cyclase
in the cockroach brain, and lobster hemolymph. In addition
to changes in cyclic AMP, octopamine in the cockroach brain
also activates the glycogen phosphorylase (23), subsequently
increasing glycogenolysis, resulting in the depletion of
large stores of glycogen in the ganglia, most likely from
the carbohydrate rich perineurial glial cells(24). The
cockroach brain contains substantial amounts of octopamine
which suggests that octopamine plays an important role in
the cyclic AMP mediated regulation of glycogenolysis and
affords additional evidence that it is a neurotransmitter in
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the insect nervous tissue. In study done with lobster, it
was found that the nervous system contains no NA and large
amounts of octopamine(25). The peripheral nerves from the
lobster thoracic ganglia are rich in octopamine and its
synthetic enzymes, including tyramine beta-hydroxylase(26).
Octopamine does not appear to be present at the surface of
the nerve cells. The cells are not electrically activated
by superfusing a high concentration of octopamine, which
suggests that the octopamine is present in the root cells,
rather than in the nerve ending. Octopamine also stimulates
heart rate and beat strength through effects on cardiac
ganglion cells, further suggesting its role as
neurotransmitter. In firefly lantern, octopamine effects
strong luminescence (27, 28). Because the effects of
electrical stimulation of the lantern may be mimicked by
phosphodiesterase inhibitors(29), and since it has been
shown that the lantern contains octopamine sensitive
adenylate cyclase, it has been proposed that octopamine
effects are via cyclic AMP.
C The purpose of this study 
In an effort to understand the nature and organization
of biological systems, the anatomical distribution and
levels of biochemical markers expressed in rhythmic manner
in insects and crustaceans have been studied. Insects, in
particular the cockroach L. maderae, offer an excellent
model analogous to the vertebrate system in which to
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investigate anatomically localized components of the
circadian system.
The circadian system in the cockroach L. maderae, is
one of the best understood in terms of its anatomical and
functional organization. The circadian system that controls
the locomotor activity pattern in the cockroach consists of
four functionally defined components. These components are
two mutually coupled pacemakers that generate the primary
timing cue for rhythms, photoreceptors for entrainement, and
two coupling pathways, one that mediates the flow of
entrainement information from the photoreceptor to each
pacemaker and a second that couples each pacemaker to the
overt rhythm it controls(30). The pacemakers in L. maderae
are situated within the lobula neuropil in each optic lobe.
Each pacemaker receives information from photoreceptors in
the compound eye. This information resets the clock exactly
to a 24-hour period each day. Each of the two pacemakers
found in the cockroach optic lobes has three known output
(efferent) pathways, which regulate the circadian rhythm of
locomotor activity, eye sensitivity to light and metabolism
respectively. In a study concerning the level of metabolic
activity in the nervous tissue by Lavialle and
associates(31) in 1989 for example, they reported a
significant change in energy metabolism per 24-hour period.
Despite the fact that each of these efferent pathways
originate in the lobula neuropil, it is not yet known
whether the same cells regulate the expression of each of
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these rhythms via efferent neural pathways. The
identification of a neurochemical marker that varies on a
circadian basis would be an important first step in trying
to answer this question. The identification of such a
neurochemical marker controlled by the lobula neuropil would
enable the discovery of the neurons that produce the
neurochemical marker which could then be traced anatomically
toward the pacemaker. Octopamine, a prominent
neurotransmitter in the cockroach brain offers a likely
neurochemical marker candidate. It has been shown that in
some arthropods the brain and hemolymph levels of octopamine
do vary on a temporal basis(32). Woodring and associates
(32) reported daily rhythm in brain octopamine level in
female house cricket Acheta domesticus.
As a first step toward determining whether or not
octopamine is a potential neurochemical marker useful in
tracing neural pathways toward the pacemaker, the purpose of
our study will be to determine the existence of variation in
brain levels of octopamine in the cockroach L. maderae. The
study will be conducted at 6-hour intervals throughout a 24-
hour period in order to scan for temporal variation. In
order to carry out this study, we initially had to develop a
highly specific method for the detection of octopamine by
high pressure liquid chromatography (HPLC) with amperometric
electrochemical detection (EC), previously unreported in the
literature. The presence of octopamine in the cockroach
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brain was subsequently confirmed by gas chromatography
/mass spectrometry.
D. The development of assay methods for octopamine 
The occurrence of octopamine was demonstrated in
mammalian organs and in human urine after inhibiton of
monoamine oxidase (MAO) (32), and using ion-exchange resin to
separate selectively, and to concentrate minute amounts of
amine for two dimensional chromatography. The enzyme MAO
degrades octopamine into p-hydroxymandelic acid. It was not
until 1968 that octopamine was identified in mammalian
tissue by a very sensitive but nonspecific enzyme
radiochemical assay (ERA) developed by Axelrod et al. for
invertebrates(33). Octopamine was found, using the ERA
technique, among other organs, in several sympathetically
innervated organs of the Sprague-Dawley rat(34), and other
mammals(32). The amine has also been detected in human
blood plasma and platelets(35). The technique of Axelrod et
al. (33) utilizes the bovine adrenal enzyme
phenylethanolamine N-methyltransferase to transfer the
methyl group from C14-S-adenosylmethionine to the nitrogen
of octopamine to form C14-N-methyloctopamine (synephrine).
This enzyme is specific for those phenylethylamines having a
beta-hydroxyl group. The radiolabeled synephrine formed
during the reaction is removed by toluene:isoamyl alcohol
solvent extraction at pH 10, and estimated by scintillation
counting. A number of biogenic amines are susceptible to N-
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methylation under these conditions, and the solvent system
commonly used to extract deuterated synephrine from the
reaction mixture also extract significant amounts of other
amines (36, 37). Therefore, the identification of octopamine
is achieved by the use of thin-layer chromatography.
Failure to perform chromatographic checks may account for
some of the conflicting reports in the literature concerning
the octopamine concentrations in various tissues (38, 39).
It is desirable that chromatographic purification of the
[3H)synephrine formed in the octopamine assay be performed
routinely on all samples processed through the ERA
procedure. The technique of Axelrod et al. (33) determined
the concentration of octopamine in the rat brain to be 4.7
ng/g of brain tissue. The largest concentration is found in
the adrenal gland amounting to 461 ng/g(33). The major
drawback of the enzymatic assay is the inability to
distinguish the three isomers, ortho, para, and meta
octopamine(34, 35). The method of Danielson and
associates(40) offers the advantage that the chromatographic
procedures used are exhaustive and permit the separation of
the N-methyl derivatives of the meta- and para- isomers of
octopamine. Although meta-octopamine is not normally
detectable in most tissues(41), it constitutes a significant
proportion of the octopamine present in the salivary
gland(39) and can be detected in the brain after the
administration of MAO inhibitor(40). Although considerably
more laborious than other methods, the technique of
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Danielson et al. (41) has considerable advantages with regard
for specificity that for several years was regarded as the
method of choice.
Techniques for the identification of octopamine abound.
With the advances made in the field of chromatography,
additional techniques have been investigated and developed.
Scientists working in the field of gas chromatography (GC),
HPLC, and gas chromatography/mass spectrometry (GC/MS) have
developed numerous excellent techniques for elucidation of
derivatized octopamine. Brooks and Horning (42, 43)
describe an excellent method for the estimation and
identification of acetylated derivative of octopamine and
other biogenic amines, using GC. Edwards and associates
(44) in 1972 described a methodology for the identification
of the 0-trimethylsily1 (0-TMS), N-dinitrophenyl (N-DNP)
derivative of octopamine on GC with Electron Capture
Detector (ECD). They report the detection of octopamine in
rat brain and liver in picogram levels. Buck and
colleagues(45) in 1977 described an assay method for
octopamine based upon GC/MS. Octopamine, extracted from
tissues with perchloric acid, is purified by column
chromatography on Dowex 50, derivatized with pentafluoro
propionic acid anhydride (PFPAA), and separated by gas
chromatography on OV-17 prior to mass spectrometric
analysis. Although less sensitive than the radiochemical
methods, this technique is capable of providing valuable
corroboration of results obtained with more sensitive but
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less definitive radiochemical procedures. Bailey et al. (46)
in 1982 described a methodology for the identification of
octopamine using (HPLC) with amperometric electrochemical
detection. The procedure uses a silver/silver chloride
(Ag/AgC1) reference electrode, which was subject to drift
due to the diffusion of chloride ions from the reference
electrode into the mobile phase. Difficulties encountered
with amperometric detection has kept the development of
methodologies nonexistent to date. Bailey and colleagues
(46) reported using an oxidation potential of 0.9 V vs
Ag/AgC1 electrode to determine octopamine levels; however
they did not generate cyclic voltammogram for octopamine.
The authors state that due to the high oxidation potential
needed to oxidize octopamine, amperometric detection is not
an attractive method to quantitate octopamine. In 1983,
Martin and associates(47) developed a method using HPLC
with coulometric electrochemical detection. The authors
report that oxidizing the mobile phase prior to injection of
the sample reduces significantly the background noise, and
thus enhances the sensitivity of the methodology. In 1984,
Ibrahim et al.48) reported a method for quantitative
measurement of octopamine using capillary column gas
chromatography electron capture negative chemical ionization
(NCI) GC/MS. They reported the existence of the three
isomers of octopamine in human urine. The deuterated amine
was subjected twice to cation exchange chromatography, using
5 cm x 0.8 cm column of AG 50W - X2 ion-exchange resin. The
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resultant octopamine fraction was derivatized with (PFPAA),
and under electron capture NCI GC/MS, the PFPAA derivatives
gave N7 and (M-HT)- ions which were sufficiently abundant to
be suitable for selected ion monitoring. The published
methodologies for the detection, quantification, and
identification of octopamine most commonly use NCI GC/MS by
electron capture(49, 50). To date there is not one
universal method for octopamine determination.
E. Chemistry of Octopamine 
Octopamine is an aromatic primary monoamine, it is an
alcohol, and is named as beta-hydroxyphenylethanolamine.





The presence of a beta- hydroxy group makes octopamine
unstable at high temperature. The chemical bond between the
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nitrogen and carbon is easily broken. A naturally occurring
form of octopamine is the D- form. Octopamine is believed
to be synthesized in vivo by way of phenylalanine. The
enzymes responsible for the biosYnthesis of octopamine are
phenylalanine 4-hydroxylase (PAN), aromatic L-amino acid
decarboxylase (AADC), and dopamine- beta- hydroxylase
(DBH) (51). There are several possible pathways for these
reactions to occur. Examples of choices available for
octopamine synthesis from phenylalanine are: via tyrosine,
tyramine, octopamine pathway, or phenylalanine,
phenylethylamine, tyramine, octopamine pathway. It could
also be synthesized from the dehydroxylation of
catecholamines dopamine and noradrenaline by DBH enzyme.
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FIGURE 1. Biosynthesis and Degradation of Octopamine
15
In vertebrates, octopamine is metabolized by monoamine
oxidase (MAO) enzyme to p-Hydroxymandelic acid. Studies
have shown that MAO inhibitors produce a rise in octopamine
levels in tissue (52), indicating the importance of this




Varian HPLC Model 5000
Varian 4270 Integrator were
with a 25 µL injection loop, and
obtained from Varian Analytical
Instruments, 220 Humboldt Ct., Sunnyvale, CA 94089, USA.
BAS Model 100 electrochemical analyzer, BAS LC-4B/17A
amperometric detector, glassy carbon electrode and Ag/AgC1
reference electrode were purchased from BAS Bioanalytical
Systems Inc., 2..701 Kent Ave., West Laffayette, IN 47906,
USA. A VisiprepTM SPE vacuum manifold, complete with
adapters used in the solid phase extraction, Supelcosil LC-
18 HPLC column, and 1 mL Supelcosil NH2 solid phase
extraction columns were purchased from Supelco, Inc.,
Supelco Park, Bellefonte, PA 16823-0048, USA.
The gas chromatography (GC) system was HP 5890 from
Hewlett-Packard, Rte. 41, P. 0. Box 1100, Avondale, PA
19311, USA. The GC column was a Rtx-5, 20m x 0.23mm, 0.1
microns, df from the Restek Corp., 110 Benner Cir.,
Bellefonte, PA 16823, USA. The mass spectrometer system was
a Kratos Concept IH/Double Focusing EB Geometry El, from





Methylene chloride HPLC GC/MS Grade and concentrated
phosphoric acid were obtained from Fisher Scientific, 711
Forbes Ave., Pittsburgh, PA 15219, USA. Acetonitrile HPLC
Grade, methyl alcohol HPLC Grade, 3,4-dihydroxybenzylamine
hydrobromide (DHBA), 1-heptanesulfonic acid sodium salt, and
N,0-bis-(trimethylsily1)-trifluoroacetamide (BSTFA) were
purchased from Aldrich Chemical Co., Inc., P.O. Box 355,
Milwaukee, WI 53201. The DL-p-octopamine hydrochloride,
ethylenediaminetetrahydroacetic acid (EDTA), free acid, and
potassium phosphate dibasic were purchased from Sigma
Chemical Co., P.O. Box 14508, St. Louis, MO 63178, USA.
Helium carrier gas was supplied by the Central Welding
Supplies, Lexington, KY 40205, USA. Acetic anhydride,
acetic acid, methanol, ethyl acetate, all ACS grade were
purchased from the J&W Scientific, 91 Blue Ravine Rd.,
Folsom, CA 95360 USA. A C18 reverse phase 25 cm x 21 mm
with 5 micron particle size column, and 1 mL LC-NH2
Supelclean solid phase extraction cartridges were purchased
from Supelco Inc., Supelco park, Bellefonte, PA 16823, USA.
C. procedure
1. Preparation of the mobile phase. The mobile phase
was prepared by dissolving 8.7090 g of K2HPO4 in about 400
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mL of HPLC grade water into which 0.100 g of EDTA was then
added and allowed to aissolve completely. Sixty mL of HPLC
grade methanol was added. The solution was thoroughly
mixed. The volume was brought up to about 950 mL with HPLC
grade water. The pH of the solution was adjusted to 6.5
with concentrated phosphoric acid. Then the volume was
brought up to the one liter mark. At this point, about 50
mL of the mobile phase was withdrawn for use in the brain
extraction. Then 0.30 g of 1-heptane sulfonic acid was
added to the remaining 950 mL of mobile phase. The mobile
phase was then allowed to stand for 10-12 hours prior to
HPLC analysis.
Following the preparation of the mobile phase, the
HPLC instrument was powered on and a solution of 80/20
methanol/water mixture was run through the column for 10 -12
hours. Prior to use, the mobile phase was filtered through
a 0.45 gm Nylon 66 membrane filter and degassed for a
minimum of 15 minutes. At the end of twelve hours, the
methanol/water mixture was removed from the HPLC and
replaced with previously degassed mobile phase containing
the ion-pair reagent (heptane sulfonic acid). The flow rate
was adjusted to 0.6 mL/min and the column temperature was
set at 30°C. The mobile phase was allowed to run for 10-12
hours to allow the column packing to equilibrate with the
mobile phase. At the end of this time, the detector was
turned on, the reference and the working electrodes were
positioned in place and connected, the sensitivity was set
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to 0.5nA, and the voltage was set at 1.040 V vs the Ag/AgC1
reference electrode. The detector was operated in an
oxidation mode. The electrodes were allowed to equilibrate
for about 30 minutes to 3 hours, until a steady baseline was
achieved. Octopamine standard containing 0.4 ng of
octopamine/µL was prepared by carefully weighing out 2.5 mg
of octopamine and dissolving it in a 25 mL volumetric flask
using the mobile phase containing the heptanyl sulfonic
acid. Next, a 100 µL of this solution was withdrawn and
diluted in another 25 mL volumetric flask. This solution
was then called octopamine solution Number 2. The 0.64
ng/µL DHBA standard was prepared by carefully weighing out
4.0 mg of DHBA and dissolving it in 25 mL mobile phase
containing heptane sulfonate, then withdrawing 100 µL of
this solution and diluting it into another 25 mL volumetric
flask. This became DHBA solution Number 2. The sensitivity
of the detector was determined each time a new mobile phase
was prepared. This was achieved by preparing the 0.4 ng/µL
and the 20 ng/µL of octopamine standards and injecting 25 µL
of each solution to evaluate the suitability of the obtained
peak heights for octopamine in the cockroach brain extract.
The 0.4 nanogram octopamine standard was prepared by taking
2 mL of octopamine solution Number 2 and diluting it to 10
mL with the mobile phase. Then 500 µL of this solution was
mixed with the 500 µL of DHBA standard solution Number 2.
Just prior to the surgery, the standard containing 0.64 ng
of DHBA was prepared using the mobile phase not containing
20
ion-pair reagent to facilitate the octopamine extraction, by
weighing out 4.0 mg of DHBA and dissolving it in 25 mL
volumetric flask. One hundred µL of this solution was
withdrawn and placed into another clean 25 mL volumetric
flask. The volume was brought up to the 25 mL mark. The
flask containing 0.64 ng of DHBA/µL was then taken to the
surgery room.
2. Electrochemical behavior study. Initial work
was done to determine the electrochemical behavior of
octopamine and DHBA. This was achieved by generating the
cyclic voltammogram for each compound. The cyclic
voltammogram was obtained by using the BAS 100 instrument,
the sensitivity of which was set at 1.0 E-4 (A/V). Ag/AgC1
reference electrode and glassy carbon working electrode were
used. Octopamine and DHBA were prepared by dissolving 28.4
mg of octopamine and 33.0 mg of DHBA in 50 mL of mobile
phase respectively. About 10 mL of each solution was
withdrawn from the flask and placed in the electrolysis cell
and bubbled with nitrogen for five minutes. The potential
scan was from 0.0 mV to 1100 mV and back to 0.0 mV at a
rate of 250 mV/sec. The result is shown in Figure 2. The
cyclic voltammogram for DHBA standard was run from -50 mV to
1500 mV to -50 mV as shown in Figure 3.
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TOP = 8.9791e -5 A = 2944 CTS = FS/11






HIGH E (MV) = 1100
LOW E(MV) = 0
V (MV/SEC) = 250
INIT P/N = POSOTIVE
SWEEP SEGMENT = 2




PEAK POTENTIAL (MV) = +730
PEAK CURRENT (A) = 5.9017E -5
CATHODIC:
Figure 2. Cyclic voltammogram for octopamine.
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TOP = 8.979e-5 A = 2944 CTS = FS/11





INIT E(MV) = -500
HIGH E(MV) = 1100
LOW E(MV) = -500
V (MV/SEC) = 250
INIT P/N = POSITIVE
SWEEP SEGMENT =2




Figure 3. Cyclic voltammogram for internal standard
DHBA.
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A solution containing a 50:50 mixture of 0.04 ng/µL
standard octopamine and 0.06 ng/µL standard DHBA was used in
generating the hydrodynamic voltammogram. The generation of
the hydrodynamic voltammograms for octopamine and DHBA used
HPLC with amperometric electrochemical detection. The range
was from 100 mV to 1100 mV vs Ag/AgCl. The electrodes were
allowed to equilibrate between each successive downward
adjustment of the output voltage. A plot of the current
generated vs the applied potential is shown in Figure 4.
Each point on the graph represents an average of three
successive injections of 25 µL of the octopamine:DHBA
standard mixture described above. A value of 1.040 V was
chosen from the graph in Figure 4 as the optimum operating
potential for our electrochemical detector.
The limit of detection for octopamine used in our
study was determined by increasing the sensitivity of the
detector to the point where a measurable background was
obtained. Octopamine standard was injected followed by a
subsequent dilution until the ratio of peak height of the
octopamine and the background signal was approximately equal
to 3. Figure 5 shows a chromatogram of an injection of 70
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Applied potential vs Ag/AgCI reference electrode
Figure 4. Hydrodynamic voltammogram for standard
octopamine and DHBA (internal standard).
25
FIGURE 5. HPLC Chromatogram illustrating limit of
detection. The detector was set at 0.05 nA
sensitivity.
3. Cockroach brain preparation and liquid-liquid
extraction. The experimental cockroaches L. maderae were
initially raised in the controlled environment under the
12:12 light/dark cycle, and ambient room temperature. At
least one week prior to surgery, the cockroaches were
acclimatized to 25° + 2° C temperature, and 12:12 light/dark
cycle environment within the environmental chambers. Light
onset was at 0800 h. During this time, the daily activity,
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as shown in Figure 6, was recorded for representative
cockroaches as during the acclimation period.
Brain extracts were obtained over a 24-h period at 6-h
intervals, beginning at 0800 h and ending at 0200 h, giving
four readings of octopamine levels in the cockroach brain.
Immediately prior to the surgery, each cockroach was removed
from the plastic holding cage within the environmental
chamber and flash frozen in -70° C petroleum ether. This
method minimized trauma to the insect thus avoiding a
possible stress induced rise in hemolymph levels of
octopamine. The head of the cockroach was then placed
through a hole cut in the lid of a plastic petri dish. Tape
was placed behind the head to maintain its position. The
lid was placed over the petri dish base and the dish
positioned on the illuminated stage of a dissecting
microscope. An incision was made through the cuticle of the
head capsule encompassing both antennae, using a fractored
razor blade scalpel. The cuticle was removed, exposing the
brain. The left optic nerve was severed using iridectomy
scissors, and the brain lifted out cf the head enclosure.
The right optic nerve was cut at this time to free the
brain. The brain was cleaned of any excess fat and
carbohydrates prior to its removal. Two brains were placed
into an Elrejhen tissue homogenizer to which 100 µL 0.64 ng
of DHBA/µL, 50 µL of 0.1 N perchloric acid, (HCL04), and 50
µL of the mobile phase without heptane sulfonic acid was
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Figure 6. Cockroach activity chart.
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The homogenate was transferred to a microcentrifuge tube and
centrifuged at 40 C for 30 min at 20,200 x g. A
micropipette was used to transfer the supernatant from the
microcentrifuge tube to transfer it to another clean
microcentrifuge tube. The pellet was discarded. One mL of
8:1 heptane:chloroform (v/v) mixture was added, and the
solution vortexed for 30 sec. The aqueous bottom layer was
transfered to another clean microcentrifuge tube using a lcc
tuberculin syringe. Five µL of this extract was analyzed
by HPLC. Figure 7 shows a representative chromatogram of
brain extract under the described conditions.
-
Figure 7. HPLC-EC chromatogram of 5 µL of brain
extract without the use of LC-NH2 SPE column.
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4. Method development using solid phase extraction for
quantification of brain octopamine in L. maderae. As can be
seen from Figure 7, in order to quantify and subsequently
identify the octopamine in the cockroach brain, it was
necessary to develop a suitable clean up method for the
determination of octopamine in the cockroach brain. It was
found that NH2 solid phase extraction columns using 50:50
(v/v) methylene chloride: methanol as a conditioning solvent
worked best, the result being shown in Figure 8.
As part of our method development, it was necessary to
determine the optimum elution volume to use to elute the
sample. A 100 µL of 0.4 ng/µL of the octopamine standard
was allowed to pass through the conditioned column followed
by washing the sample one time with 100 µL of the mobile
phase. The collected eluent was analyzed by HPLC with
amperometric detection for the presence of octopamine. A
second sample of 100 µL of the above octopamine standard was
put on the conditioned LC-NH2 column and washed twice with
100 µL of the mobile phase. The eluent was analyzed for the
presence of octopamine. The procedure was repeated until
the optimum wash volume was determined by calculating the
amount of octopamine present in each of the eluates, using a
standard calibration curve. The percent recovery study was
performed by constructing an octopamine standard curve
without the use of the solid phase extraction column. A
linear regression analysis was performed on the data. Then
100 µL of the 0.4 ng/µL octopamine standard was passed
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Figure 8. HPLC chromatogram of 25µ1, injection of brain
extract after the clean-up wtih LC-NH2 SPE column.
32
through the conditioned solid phase extraction column, and
the percent recovery for octopamine was calculated. A
linear regression analysis was used to establish the values
for the equation of straight line from which the results
were subsequently obtained. The elution volumes and
corresponding recovery of octopamine from the NH2 column is
shown in Table 1. The results in graphic form are shown in
Figures 9 and 10. The optimum elution volume was found to
be 400 µL.
TABLE 1
Percent recovery of octopamine from LC-NH2 SPE
columns using different elution volumes
Wash Volume Peak Height Concentration % Recovery





0.00 0.00 40.00 0.00 0.00
100.00 0.00 5.00 0.00 0.00
200.00 29.00 3.30 0.47 4.00
300.00 64.00 2.50 1.05 42.00
400.00 120.00 2.00 1.97 99.00
500.00 97.00 1.70 1.59 94.00
600.00 83.00 1.40 1.36 97.00
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Figure 10. Optimum elution volume for the recovery of
octopamine form LC-NH2 SPE column.
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For percent recovery of DHBA, the same elution volumes were
used as were for octopamine. The DHBA standard curve was
constructed as shown in Figure 11, then the 0.32ng/µL DHBA
standard was passed through the LC-NH2 SPE column. The
percent recovery for DHBA was around 98 percent as is shown
in Table 2. Upon establishing optimum elution volumes for
octopamine, it was found that using one LC-NH2 SPE column
did not give completely satisfactory results with the brain
extract. Therefore the entire volume of the eluted sample
from one conditioned LC-NH2 column was passed through a
second conditioned LC-NH2 SPE column. This time, the sample
was allowed to completely run off the solid phase packing
without an additional wash. The recovery for the second
column was about 79-80 percent for DHBA and 80-82 percent
for octopamine. The results are shown in Table 2.
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TABLE 2
Recovery of octopamine and DHBA using two LC-NH2 SPE
columns in sequence.
Eluting compound % recovery LC-NH2 SPE column
First column Second column
Oct opamine 97- 99 80 - 82
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Brain extracts and standards were treated the same way.
One mL NH2 solid phase extraction cartridge was conditioned
with exactly 0.5 mL of 50 : 50 mixture of methanol :
methylene chloride (CH2C12), followed by 1 mL HPLC water and
2mL of the octopamine mobile phase, respectively. The
washings were discarded. One hundred µL of the pooled brain
extract from two cockroaches was passed through the first
column down to the first frit line marked on the cartridge
as shown in Figure 12, followed by a subsequent washing with
400 µL of mobile phase. The eluent was collected into a
clean microcentrifuge tube, and passed through a second
conditioned NH2 solid phase extraction cartridge this time
all the way through past the second frit line. Twenty-five
microliters of the collected eluent was then injected on to
the Supelcosil LC18 HPLC Reverse Phase Column, and detected
using the amperometric electrochemical detector. Each
of specimen was injected in
triplicate injection of one
octopamine / DHBA standard.
triplicate, followed by a




shown in Figures 13, 14. At the end of each of the 24 hour
runs, peak heights of octopamine and that of DHBA in the
standard and in the cockroach brain were carefully measured
and recorded. The three values were averaged, and the
resulting values of peak height of octopamine / peak height
of DHBA ratio vs the concentration of standard octopamine











Figure 12. Illustration of an SPE column.
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Figure 13. HPLC chromatogram of a good baseline as
part of quality assurance.
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Figure 14. HPLC chromatograms of the octopamine
and DHBA standards used to construct
the standard curve.
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The data was subjected to a regression analysis, followed by
the construction of the standard curve which is shown in
Figure 15. The concentration of octopamine in the cockroach
brain was calculated by dividing the endogenous octopamine
peak height by the internal standard DHBA peak height and
using this value in the straight line equation obtained from
the linear regression analysis. An example of the
calculation is shown below: Equation for the straight line
is Y= MX + B where Y is the ratio of the octopamine/DHBA
peak height, M is the slope of the line, and B is the Y
intercept when there is no octopamine present. Therefore it
follows that the amount of octopamine (X) present in the
cockroach brain is: X = (Y - B)/M. B and M are obtained
from the regression analysis. Y is obtained from the ratio
of peak heights of the octopamine and the internal standard
DHBA. The weighted standard deviation was first calculated
for each of the four data sets (LN1-5, MD1-5,LF1-5, and MN1-
5) of the five REPS, and then for the five data sets
representing the REPS 1-5, and four groups (LN1, MD1, LF1,
MN1, followed by LN2, MD2, LF2, and MN2 etc.,) until all
five REPS were represented. The weighted standard deviation








octopamine/DHBA peak height ratio
octopamine concentration in ng/ALL
Figure 15. Standard curve for determining brain
octopamine level.
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SD. = \I n' (S: + Af' ) 4. rib (S: + Afb ) + 
• • • ilk (9, + M2, ) 
rt. + nh + . . . + nk - Ad:
where na...nk are the number of data points in each
data set, Sa..Sk are the sample standard deviations for each
data set, Ma...Ak are the mean for all data points in each
group, and MT is the weighted mean for all groups(54). The
data points were analyzed and if necessary a verification
run was performed on any questionable result. Finally, the
analysis of variance, ANOVA, was performed. The results of




Data for the concentration of octopamine in the cockroach
brain
REP Octopamine/ Average [OCT)/ AVG [OCT) AVG
# DHBA peak ratio 2 br. [OCT) brain tot.
1-5 height ratio ng ng ng ng
LN1 0.34 2.49 1.25
0.35 2.61 1.31
0.32 0.34 2.24 2.45 1.12 1.23
LN2 0.36 2.74 1.37
0.54 4.97 2.48
0.50 0.47 4.47 4.06 2.03 1.96
LN3 0.02 9.15 4.58
0.02 9.15 4.58
0.03 0.02 13.66 10.60 6.83 5.33
LN4 0.13 8.38 4.19
0.11 7.29 3.65
0.11 0.12 7.29 7.69 3.65 3.83
LN5 0.01 4.65 2.33
0.01 4.65 2.33
0.02 0.01 9.15 6.15 4.56 3.07
MD1 0.28 1.74 0.87
0.27 1.62 0.81
0.25 0.27 1.38 1.58 0.79 0.82
MD2 0.53 4.47 2.24
0.52 4.35 2.18
0.62 0.56 5.42 4.75 2.72 2.38
MD3 0.18 8.67 4.34
0.19 9.24 4.62
0.19 0.19 9.24 9.05 4.62 4.53
MD4 0.13 8.38 4.19
0.11 7.29 3.65
0.13 0.12 8.38 8.02 4.19 4.01
MD5 0.01 4.65 2.33
0.01 4.65 2.33
0.02 0.01 9.15 6.15 4.58 3.08
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TABLE 3 continued...
LF1 0.15 6.65 3.33
0.15 6.65 3.33
0.15 0.15 6.65 6.65 3.33 3.33
LF2 0.63 5.53 2.78
0.60 5.21 2.61
0.66 0.66 5.85 5.87 2.93 2.77
LF3 0.18 8.67 4.34
0.17 8.09 4.05
0.20 0.18 9.82 8.86 4.91 4.43
LF4 0.16 10.01 5.01
0.15 9.47 4.74
0.18 0.16 11.10 10.19 5.55 5.10
LF5 0.02 9.15 4.58
0.02 9.15 4.58
0.02 0.02 9.15 9.15 4.58 4.58
MN1 0.16 7.13 3.56
0.16 7.13 3.56
0.15 0.16 6.65 6.97 3.33 3.49
MN2 0.60 5.21 2.61
0.55 4.68 2.34
0.51 0.55 4.26 4.72 2.13 2.36
MN3 0.14 6.36 3.18
0.17 8.09 4.05
0.15 0.15 6.94 7.13 3.47 3.56
MN4 0.19 11.65 5.83
0.19 11.65 5.83
0.20 0.19 12.19 11.80 6.10 5.92
MN5 0.15 6.65 3.33
0.15 6.65 3.33
0.13 0.14 5.70 6.18 2.85 3.09
LN = Lights on, MD = Midday, LF = Lights off, MN =
Midnight, AVG pk. = average peak height, AVG tot. = average




Results from the regression analysis for 5 REPS
REP # df B M R2
1 1 0.139 16.144 0.995
2 1 0.106 18.936 0.974
3 1 0.029 3.477 0.999
4 1 -0.239 3.672 0.982
5 1 -0.000 0.444 0.990
REP # = replication number, df = degrees of freedom,
B= y intercept, M= slope.
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TABLE 5
Statistical results of the octopamine determination in
the cockroach brain.
REP # [Oct] ng/brain Avg wAvg sSTD wSTD
LN1 1.25 1.31 1.12 1.23 0.10
LN2 1.37 2.48 2.03 1.96 0.56
LN3 4.58 4.58 6.83 5.33 1.30
LN4 4.19 3.65 3.65 3.83 0.31
LN5 2.33 2.33 4.56 3.07 3.08 1.29 1.68
MD1 2.38 3.56 2.14 2.69 0.76
MD2 2.24 2.18 2.72 2.38 0.30
MD3 4.34 4.62 4.62 4.53 0.16
MD4 4.19 3.65 4.19 4.01 0.31
MD5 2.33 2.33 4.58 3.08 3.34 1.30 1.07
LF1 3.33 3.33 3.33 3.33 0.00
LF2 2.78 2.93 2.61 2.77 0.16
LF3 4.34 4.05 4.91 4.43 0.44
LF4 5.01 4.74 5.55 5.10 0.41
LF5 4.58 4.58 4.58 4.58 4.04 0.00 0.90
MN1 3.56 3.56 3.33 3.48 0.13
MN2 2.61 2.34 2.13 2.36 0.24
MN3 3.18 4.02 3.47 3.56 0.43
MN4 5.83 5.83 6.10 5.92 0.16
MN5 3.33 3.33 2.85 3.17 3.70 0.28 1.22
LN = Lights on, MD = Midday, LF = Lights off,
MN = Midnight, Avg = average, wAvg = weighted average,
sSTD = sample standard deviation, wSTD = weighted




Comparison of results for REPS 1-5
analysis in the cockroach brain
from octopamine
REP# [Oct] ng/brain Avg wAvg sSTD wSTD
LN1 1.25 1.31 1.12 1.23 0.10
MD1 2.38 3.56 2.14 2.69 0.76
LF1 3.33 3.33 3.33 3.33 0.00
MN1 3.56 3.56 3.33 3.48 2.68 0.13 0.97
LN2 1.37 2.48 2.03 1.96 0.56
MD2 2.24 2.18 2.72 2.38 0.30
LF2 2.78 2.93 2.61 2.77 0.16
MN2 2.61 2.34 2.13 2.36 2.37 0.24 0.45
LN3 4.58 4.58 6.83 5.33 1.30
MD3 4.34 4.62 4.62 4.53 0.16
LF3 4.34 4.05 4.91 4.43 0.44
MN3 3.18 4.02 3.47 3.56 4.46 0.43 0.96
LN4 4.19 3.65 3.65 3.83 0.31
MD4 4.19 3.65 4.19 4.01 0.31
LF4 5.01 4.74 5.55 5.10 0.41
MN4 5.83 5.83 6.10 5.92 4.72 0.16 0.90
LN5 2.33 2.33 4.56 3.07 1.29
MD5 2.33 2.33 4.58 3.08 1.30
LF5 4.58 4.58 4.58 4.58 0.00
MN5 3.33 3.33 2.85 3.17 3.48 0.28 1.12
LN = Lights on, MD = Midday, LF = Lights off,
MN = Midnight, Avg = average, wAvg = weighted average,
sSTD = sample standard deviation, wSTD = weighted




ANOVA results for brain octopamine levels in L. maderae
Source of variation df SS MS F = 2.46
- f between groups 3 2.55 0.85
Y - within groups 16 26.84 1.68
0.51
df= degrees of freedom, SS = sums of squares, MS = mean
of squares, F = between group variance / within group
variance.
octopamine concentration in ng/brain
4.6 
The differences in results are not statistically significant
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FIGURE 16. Variation of octopamine level per 24 hour
period in the cockroach brain.
52
5. Confirmation of octopamine by GC-MS. For the GC/MS
confirmation, the brain sample was treated the same as it
was for HPLC analysis. The elution time of octopamine on
the day of the fraction collection was determined to be 3
min and 45 sec. The total time of the peak was about 30
sec. The initial waiting time was determined by starting
the stop watch at the point of injection, and timing until
the first appearance of the peak. The peak width was
determined by measuring the time in seconds it took from the
beginning of the peak to the end of the peak. Upon
establishing the appropriate collection time, the detector
was turned off, and the column line disconnected at the
detector so that the fraction was manually collected into a
clean glass tube. The injection was repeated, and
collection of fractions continued until an entire sample of
brain extract from two cockroaches was used up. The
fraction was then placed into a box of dry ice and
transported along with a sample of pure unreconstituted
standard of octopamine to Dr. Jan St. Pyrek's Mass
Spectrometry Laboratory at the College of Pharmacy,
University of Kentucky, Lexington, USA. In the mass
spectrometry laboratory, the sample was transferred to the
freezer until the analysis time. Pure octopamine standard
was used to determine the optimum analysis parameters. The
octopamine standard was dissolved into methanol, cooled on





















At the end of 30 min, enough HPLC grade water was
added to dissolve excess acetic anhydride. This was
followed by addition of a sufficent amount of ethyl acetate
to allow the extraction of acetylated octopamine into the
top ethyl acetate layer. The extraction was repeated one
more time. The derivatized octopamine in ethyl acetate
solvent was allowed to evaporate to dryness under a nitrogen
atmosphere. At this time 50 µL of BSTFA derivatizing
reagent was added. The GC/MS injector (split mode) /
detector/ and the transfer line temperature were set to 2800
C. The mass spectrometer electronics were set to scan from
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detector/ and the transfer line temperature were set to 2800
C. The mass spectrometer electronics were set to scan from
750 - 50 amu @ 0.3sec/decade, (750 -75 is 1 decade), with
0.3 seconds interscan. Electron impact was set at 70 eV.
Characteristic peaks for the standard octopamine were at m/z
324, m/z 267, and m/z 73. The fraction from the cockroach
brain extract was brought to room temperature, evaporated to
dryness under the nitrogen atmosphere and then treated in
the same manner as described for the octopamine standard.
GC/MS results are shown in Figures 17-22.
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FIGURE 17. GC chromatogram of octopamine standard.
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FIGURE 18. Ion chromatogram of octopamine standard.
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FIGURE 19. Mass spectrum of octopamine standard.
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FIGURE 20. GC chromatogram of HPLC fraction of the
cockroach L. maderae brain extract.
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FIGURE 21. Ion chromatogram of the HPLC fraction of the
cockroach L. maderae brain extract.
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FIGURE 22. Mass spectrum of HPLC fraction of the brain
extract from cockroach L. maderae.
CHAPTER III
DISCUSSION OF RESULTS
Initial study of octopamine shows that the octopamine
is irreversibly oxidized as compared to our internal
standard DHBA which is reversibly oxidized (Figure 2, 3).
Literature does not offer information as to the possible
reason why octopamine is irreversibly oxidized, except the
fact that the reaction is irreversible. It is possible that
the exchange of electrons at the electrode is too slow for
the octopamine to be a reversible process, which then
suggests that the reaction is not governed by thermodynamics
but by kinetics. The overall reaction is not Nernstian.
Without further study of the reaction mechanism it is not
possible to answer the question concretely. In our study the
scan range was large enough to be able to detect both the
cathodic and the anodic peak. We found only the cathodic
peak for octopamine, indicating irreversibility of the
reaction, whereas there were both the anodic and the
cathodic peaks present for DHBA. The anodic and the
cathodic peaks for DHBA are highly separated, suggesting a
pseudoreversibility. The question one may pose is why is
octopamine electrochemically different from DHBA?
Structurally the two compounds are similar, but chemically
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It is not easy to answer this question, without
additional study of octopamine oxidation products. DHBA is
a catecholamine, whereas the octopamine is a phenolic amine.
The OH group on the C1 of the ethanolamine functional group
of octopamine makes this particular bond easy to break,
whereas the OH group on the ring is resonance stabilized and
is thus harder to disturb. For example, during the
oxidation at the electrodt, DHBA's two OH functional groups
may loose one hydrogen each which is quickly regained during
the reverse scan. Octopamine on the other hand may lose its
ethanolamine functional group irreversibly, or through
rearrangement becomes a different molecule altogether. A
study of the oxidation products of octopamine would afford
an answer to the elusive behavior of octopamine. In our
study we were concerned with finding the most suitable
operating potential for octopamine which would also be
compatible with our internal standard DHBA, enabling us to
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quantitate octopamine in the cockroach brain. Hydrodynamic
voltammograms of the two compounds in question show that the
optimum potential for DHBA is around 0.75 to 0.95 V vs
Ag/AgC1 reference electrode, which agrees with the value
reported by BAS (55). We determined that the optimum
applied potential for octopamine to be 1.040 V vs Ag/AgC1,
as can be seen in Figure 4.
Our study revealed that the preinjection column mobile
phase oxidation was unnecessary; however, there are a few
points to bear in mind when using this high sensitivity
method. These are mentioned here. It is very important to
prepare the mobile phase with the utmost care. This is to
prevent the precipitation of salts in the mobile phase which
tend to accumulate on the surface of the electrode causing
drift, and sometimes an outright electronic jam of the
detector. An effect of salt accumulation at the electrode
surface, air bubble passing through the electrode, and
electronic interference is shown in Figure 23. Degassing
the mobile phase thorougly can not be over-emphasized to
prevent air bubbles from adhering to the electrode surface
also causing the baseline drift in the upward direction.
Cleaning the column regularly will also eliminate
particulates that get accumulated on the column during the
run, and which tend to elute occasionally during the
analysis adding to excess peaks.
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During our experiment we found that the best way to
keep the column in good condition was to clean it for 10 h
with 80 - 100 percent acetonitrile after the analysis of
sample and prior to storage by letting the cleaning solvent
run at the same elution volume as the sample was run. Prior
to the next analysis, we allowed 80:60 methanol:HPLC grade
water mixture to run for approximately 8-10 h before
changing to the mobile phase. We found that this method
gave a stable baseline in a relatively short time, 30 min to
3 h after the detector was turned on.
The limit of detection for our instrument was found to
be around 70 pg of octopamine as seen in Figure 5.
The remarkable results obtained using solid phase
extraction NH2 column in conjuction with methylene
chloride/methanol conditioning solvent is shown in Figure 8.
The amino solid phase extraction column was chosen by
assuming that there are many small molecular weight, highly
polar, non- hydroxy amino molecules left in the initial
brain extract that interfered with octopamine analysis on
the HPLC C18 reverse phase column. The amino solid phase
extraction column with our conditioning solvent afforded a
significant retention of these interferring compounds and
allowing only the desirable analyte to pass through for
subsequent HPLC analysis. Our method simplified the sample
matrix, making it less complex and easier to analyze. The
major driving force behind the analyte isolation in solid
phase extraction is a differential affinity for the analyte
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between the solvent and the packing material. This means
that the octopamine and DHBA in our study have greater
affinity for the mobile phase than for the packing material,
and are thus eluted almost 100 percent using one LC-NH2 SPE
column, and about 80 percent if using two columns in
sequence and bypassing further washing of the sample from
the second column, as was determined from the percent
recovery study in Figure 10. The interferring substances
are retained on the solid phase extraction column. The
capacity of the solid phase extraction column is not
unlimited. In our study we found that using 1 mL solid
phase extraction column was not sufficient to clean up two
brain samples satisfactory. We therefore used two 1 mL
solid phase extraction columns in series. An alternative
would have been goina to a larger capacity solid phase
extraction column. However, this option is not desirable
due to the dilution factor involved using a larger volume
solid phase extraction column. It must be pointed out that
a 2 mL or larger column size would have been just as
efficient as were the 1 mL solid phase extraction columns we
used in our experiment. Our sample size required us to use
the smaller volume solid phase extraction columns.
Our HPLC system utilized reverse-phase ion-pair
chromatography with amperometric electrochemical detection.
The terms reverse-phase ion-pair chromatography and
amperometric detection need clarification. Ion-pair
chromatography is essentially an alternative to ion-exchange
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chromatography for the separation of ionic compounds. In
order to make the ionic compound of interest interact with
the nonpolar stationary phase a counter ion is added to the
mobile phase. The ionic compound of interest and the
counter-ion form an ion pair that when combined have
sufficient lipophilic character to be retained by the
nonpolar column. If the counter-ion was not present, the
compound of interest would not be retained by the column at
all, or it would exhibit severe tailing. In our experiment,
the octopamine and DHBA were the two ionic compounds of
interest, and the ion-pair reagent we used was 1-heptane
sulfonic acid sodium salt. The ion-pair and our analyte
probably formed the coupled neutral species according to the
following equation:
X+aq 4- Q-aq < > [X+Q-]aq < > [x+Q-iorg
where X+ is the protonated amino group on the octopamine and
DHBA, and Q- is the deprotonated sodium salt of 1-
heptanesulfonic acid with the negative charge being on one
of the oxygens. In this form the coupled ion-pair is
retained on the column long enough to allow a good
separation of the octopamine and DHBA from each other and
other eluting species. The amount of counter-ion added to
the mobile phase is the major factor governing retention
time of the analyte. Increasing the amount of counter-ion
will increase the retention time of the analyte within
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limits. Also the pH of the mobile phase is obviously
important in the formation of an ion-pair. The pH of the
mobile phase if not chosen carefully, can cause a variety of
problems, for example, at higher pH (ie. >7.0), there
appeared to be considerable precipitation of the components
in the mobile phase, which contributed to a lengthy delay in
the progress of our experiment. Temperature also has an
effect on the eluting compounds. At higher temperatures,
the elution is faster, thereby shortening the retention
time.
Reverse-phase chromatography is simply the reverse of
normal-phase chromatography. The mechanism is based on the
immiscibility of the stationary phase with the mobile phase.
In reverse-phase the stationary phase on the column is
nonpolar, for example having an C8 or C18 functional group.
The separation in reverse-phase chromatography is governed
by the partitioning of the analyte between the stationary
and mobile phase. The more soluble the analyte is in
mobile phase, the faster it will elute. To manipulate the
solubility of the analyte in the mobile phase, organic
modifiers are normally added. The most commonly used
organic modifier added to the mobile phase is methanol or
acetonitrile. In our experiment, we found that 6% methanol
added to the mobile phase gave good resolution and retention
time.
Amperometric electrochemical detection is a very
sensitive and selective analytical technique. It is used
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for the detection of electroactive substances, and has found
widespread use in neurochemistry. It is a surface
technique, and a small volume surface cell is required. In
our experiment, the thin layer cell consisted of a glassy
carbon electrode with a cell volume of less than 5 µL
volume. As an electrochemically active compound passes over
an electrode held at a potential sufficiently great for an
electron transfer to occur, a current is produced which is
directly proportional to the concentration of the compound
entering the electrochemical cell. As the concentration
changes as a function of time due to elution of the compound
from the chromatographic column, so does the current. This
is the basis for quantitative electrochemical analysis. The
schematic representation of the amperometric detection is
shown below:
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Column resolution, and adjustment of the electrode
potential improves the selectivity of amperometric
detection. In our experiment it was determined from Figure
4, that the optimum applied potential for octopamine
analysis is 1.040V vs Ag/AgC1 reference electrode.
The methodology for sample clean-up using LC- NH2 solid
phase extraction columns afforded an excellent recovery. We
did not encounter the problems with the amperometric
detection as reported by Bailey et al.(22) as discussed in
the introduction and as can be seen in Figures 8, and 12-13.
The problems we experienced were operator related, wear and
tear of consumable instrumental components and due to
improperly prepared mobile phase. These effects are shown
in Figure 23.
Octopamine when subjected to elevated temperatures is
subject to fragmentation even when partially derivatized.
Figures 13 - 18 show the results of octopamine confirmation
by El GC/MS. The two most abundant ions present are the 267
m/z and 73 m/z, and two ions of lesser abundance of 324 m/z
















Comparing Figure 19 and Figure 22, it was found that
the mass spectrum of brain octopamine exhibited the ions of
the same mass to charge ratio as the standard octopamine
confirming that the compound in our analysis was indeed
octopamine.
Examining Figure 16, it at first appears that the
octopamine exhibits a daily rhythm. But upon analysis of
variance, ANOVA, it was concluded that the F ratio was not
statistically significant, thereby indicating that the
octopamine does not exhibit a daily rhythm as postulated.
CHAPTER IV
SUMMARY
In conjuction with our study to determine the existence
of a daily rhythm for brain octopamine in the cockroach L.
maderae, we developed a convenient, inexpensive, and very
sensitive method for the determination of octopamine. The
procedure involved utilizing NH2 solid phase extraction
columns to clean up the sample prior to HPLC reverse-phase
ion-pair with amperometric electrochemical detection. Our
methodology affords excellent recovery of octopamine from
the solid phase extraction, and offers the detection of this
compound in picogram levels. The presence of octopamine in
the cockroach brain extract was confirmed by electron impact
GC/MS. This study found that the octopamine levels in
cockroach brains do not exhibit a daily rhythm.
Based on the reports in the literature regarding the
function of octopamine in the insects, as discussed in the
introduction, it would be of interest to further investigate
the levels of octopamine found in the hemolymph of the
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